GREY:RPBIF - Post by User
Post by
HippygirL74on Oct 04, 2008 12:22pm
307 Views
Post# 15504807
Think About It...
Think About It...Current market cap is about $24 MM.
If someone was to steal RBM for $24 MM, they wouldn't need to wait for FDA approval for FluA and FluB tests.
They wouldn't need to wait for FDA approval for ntproBNP testing. They wouldn't need to wait for FDA approval for the entire cardiac menu. They wouldn't need to wait for FDA approval of the automated facility that is up and running and ready set go. They wouldn't need FDA approval for the new RAMP 200 reader. They would own the patents that don't expire until 2022? or there abouts.
They don't have to wait for 3M to get its marketing and sales force ready because they are in place already!
If someone got control of RBM, they could control 3M diagnostics because 3M plans to do a lot of POC testing on the RAMP 200 platform, their first entry in this area.
Current price is absolutely ridiculous. And imho it is a buying opportunity. The POC players would love to exploit this technology. The problem is that there is no yield to value the sp. But imho it is no problem asking a few rich investors for a few million short term. i would buy if asked.
We could see a run for the company. i'm holding on to RBM.
Good luck... this is a real high stakes game now.